Skip to main content
. 2022 Oct 20;10(10):1761. doi: 10.3390/vaccines10101761

Figure 3.

Figure 3

IgGs related to SARS-CoV-2 against RBD domain of S protein induced by distinct vaccine platforms. (A) Analysis by OD of samples from nonvaccinated (n = 34), vaccinated with Pfizer (n = 8), vaccinated with Astra Zeneca (n = 38), and vaccinated with Sputnik V (n = 8). (B) Analysis by OD of samples of nonvaccinated, vaccinated with first vaccine dose, and vaccinated with second vaccine dose from COVID-19(−) and recovered COVID-19(+)participants. Cutoff values are indicated by lines. Mean ± standard deviation of the mean (SD) is shown. Central trend values and dispersion values are indicated in Table S2, Supplementary Data.